Article
Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.
Cancer research - 1 Sept 2002
Shi Yijiang, Gera Joseph, Hu Liping, Hsu Jung-hsin, Bookstein Robert, Li Weiqun, Lichtenstein Alan
Abstract excerpt
Recent work identifies the AKT kinase as a potential mediator of tumor expansion in multiple myeloma. The finding of PTEN mutations in several myeloma cell lines suggests that loss of PTEN function may be one mechanism by which AKT activity is increased in this disease. Because PTEN-deficient myeloma cells may have up-regulated activity of the mammalian target of rapamycin (mTOR), downstream of AKT, they may be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
